KNOVV aims at directing nephron spatial orientation within renal organoids to mimic in vivo kidney development.
Chronic kidney disease (CKD) is an increasing socio-economic burden, with 100 million people affected in Europe; avail...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
GECKO
Generation of cartilage-free kidney organoids: a small molec...
203K€
Cerrado
ENGINORG
Engineering kidney organoids to study the interplay between...
2M€
Cerrado
RESET
Dreaming of no more renal dialysis how self derived tissue...
2M€
Cerrado
REGMAMKID
How to regenerate the mammalian kidney
1M€
Cerrado
KIDREGEN
Ivestigating the ability of embryonic stem cell derivatives...
30K€
Cerrado
STELLAR
Stem cell based therapy for kidney repair
10M€
Cerrado
Información proyecto KNOVV
Duración del proyecto: 30 meses
Fecha Inicio: 2023-03-21
Fecha Fin: 2025-09-30
Líder del proyecto
UNIVERSITEIT MAASTRICHT
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
254K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
KNOVV aims at directing nephron spatial orientation within renal organoids to mimic in vivo kidney development.
Chronic kidney disease (CKD) is an increasing socio-economic burden, with 100 million people affected in Europe; available treatments are limited to dialysis and transplants.
Tissue engineering and regenerative medicine (TERM) aims at developing in vivo–like organs, using in vitro three-dimensional (3D) systems as new therapies. Promising TERM therapies involving self-organized renal organoids from human induced pluripotent stem cells (hiPSC) are being investigated. These kidney organoids contain the appropriate cells although heterogeneity, immature stage and lack of the spatially specific nephron orientation are still major bottlenecks. These limitations impair microphysiological form and function, which limits their research utility and clinical applications. I hypothesize that inducing spatial nephron orientation in kidney organoids will result in improved maturation and function closely mimicking the in vivo organ. To achieve this, I will optimize protocols to generate renal organoids from hiPSC.
I will identify molecules to inhibit or induce glomerulogenesis (glomeruli formation), and develop glomerulogenesis-inducing and -inhibiting hydrogels for bioprinting renal organoids. Immunostaining, qPCR, and functional assays will be used to evaluate the morphology and function of the 3D bioprinted renal organoid construct.
KNOVV will strengthen my research and academic profiles, broaden my knowledge and experience by combining developmental biology, TERM and biofabrication to improve renal organoids. My ambition is that the bioprinted renal organoid constructs with spatially directed nephrons will enable unprecedented microphysiological maturation and function. This will allow a leap beyond the current organoids state of art and ultimately lead us closer to clinical translation, offering an alternative for the growing CKD population.